73 studies found for:    "CHMP2B-related frontotemporal dementia" OR "Frontotemporal Dementia"
Show Display Options
Rank Status Study
21 Completed
Has Results
Biomarker Validation for Niemann-Pick Disease, Type C: Safety and Efficacy of N-Acetyl Cysteine
Condition: Niemann-Pick Disease, Type C
Intervention: Drug: N-Acetyl Cysteine
22 Recruiting Evaluation of Biochemical Markers and Clinical Investigation of Niemann-Pick Disease, Type C
Condition: Neimann-Pick Disease
Intervention:
23 Recruiting PiB PET Scanning in Speech and Language Based Dementias
Conditions: PPA;   Primary Progressive Aphasia;   Aphasia;   Non-fluent Aphasia;   Semantic Dementia;   Apraxia of Speech;   Primary Progressive Nonfluent Aphasia;   Progressive Aphasia
Interventions: Drug: C-11 PiB;   Drug: F-18 FDG
24 Recruiting Biomarker for Niemann Pick Type C Disease
Conditions: Niemann-Pick Disease;   Niemann-Pick Disease, Type C
Intervention:
25 Active, not recruiting Computational Tools for Early Diagnosis of Memory Disorders
Conditions: Alzheimer Disease;   Frontotemporal Dementia;   Dementia, Vascular;   Mild Cognitive Impairment
Intervention:
26 Enrolling by invitation A Composite MR Neuroimaging Marker for Alzheimer's Disease
Conditions: Alzheimer's Disease;   Mild Cognitive Impairment;   Frontotemporal Dementia
Intervention:
27 Recruiting Young Onset Dementia - the Difficult Diagnosis and the Stressful Life for the Whole Family
Conditions: Frontotemporal Dementia;   Alzheimer's Disease.
Intervention:
28 Terminated
Has Results
Hematopoietic Stem Cell Transplantation (HCT) for Inborn Errors of Metabolism
Conditions: Hurler's Syndrome;   Maroteaux-Lamy Syndrome;   Sly Syndrome;   Alpha Mannosidosis;   Fucosidosis;   Aspartylglucosaminuria;   Sphingolipidoses;   Krabbe Disease;   Wolman's Disease;   Niemann-Pick Disease Type B;   Niemann-Pick Disease, Type C
Interventions: Procedure: Stem Cell Transplantation;   Drug: Cyclophosphamide;   Drug: Campath-1H;   Drug: Busulfan
29 Terminated Safety Study of rhASM Enzyme Replacement Therapy in Adults With Acid Sphingomyelinase Deficiency (Niemann-Pick Disease)
Conditions: Acid Sphingomyelinase Deficiency;   Niemann-Pick Disease
Intervention: Drug: rhASM
30 Active, not recruiting Davunetide (AL-108) in Predicted Tauopathies - Pilot Study
Conditions: Predicted Tauopathies, Including:;   Progressive Supranuclear Palsy;   Frontotemporal Dementia With Parkinsonism Linked to Chromosome 17;   Corticobasal Degeneration Syndrome;   Progressive Nonfluent Aphasia
Interventions: Drug: davunetide (AL-108, NAP);   Drug: Placebo nasal spray
31 Recruiting Hydroxypropyl Beta Cyclodextrin for Niemann-Pick Type C1 Disease
Condition: Niemann-Pick Disease, Type C1
Intervention: Drug: 2-hydroxypropyl-beta-cyclodextrin
32 Completed Treatment Study of Frontotemporal Dementia
Condition: Frontotemporal Lobar Degeneration
Intervention:
33 Recruiting Effects of Tolcapone on Frontotemporal Dementia
Condition: Frontotemporal Lobar Degeneration
Intervention: Drug: Tolcapone
34 Terminated Amantadine for the Treatment of Behavioral Disturbance in Frontotemporal Dementia (FTD)
Condition: Dementia
Intervention: Drug: amantadine
35 Completed Efficacy and Tolerability of Memantine in Frontotemporal Dementia (FTD) Patients
Condition: Dementia
Intervention: Drug: memantine
36 Recruiting Genetic Study of Familial and Sporadic ALS/Motor Neuron Disease, Miyoshi Myopathy and Other Neuromuscular Disorders
Conditions: Amyotrophic Lateral Sclerosis;   Frontotemporal Dementia;   PLS;   Motor Neuron Disease;   Lou Gehrigs Disease;   Familial Disease;   Amyotrophic Lateral Sclerosis, Sporadic
Intervention:
37 Enrolling by invitation Imaging of Brain Amyloid Plaques in the Aging Population
Conditions: Alzheimer's Disease;   Dementia With Lewy Bodies;   Frontotemporal Dementia;   Vascular Dementia
Interventions: Drug: Pittsburgh Compound B (C-11 PiB);   Drug: F-18 FDG
38 Completed Evaluation of a Handheld Event Related Potential (ERP)/Quantitative Electroencephalography (qEEG) System (COGNISION™) as a Useful Cognitive Biomarker for Alzheimer's Disease.
Conditions: Memory Disorders;   Alzheimer Disease;   Dementia;   Cognitive Impairment;   Frontotemporal Dementia
Intervention: Device: COGNISION™ System
39 Recruiting Natural History and Biomarkers of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Caused by the C9ORF72 Gene Mutation
Condition: Amyotrophic Lateral Sclerosis
Intervention:
40 Active, not recruiting Biodistribution of 11C-PIB PET in Alzheimer's Disease, Frontotemporal Dementia, and Cognitively Normal Elderly
Condition: Alzheimer's Disease
Interventions: Radiation: 11C-PIB PET Scan;   Radiation: FDG-PET Scan

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years